Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andreas Varkaris, M.D., Ph.D.

Concepts (184)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Proto-Oncogene Proteins c-met320155610.970 Why?
Receptors, Androgen5202410880.880 Why?
Prostatic Neoplasms152024110830.820 Why?
src-Family Kinases320145380.810 Why?
Phenylthiohydantoin220242060.790 Why?
Hyperinsulinism120244020.710 Why?
Radium12016700.520 Why?
Interleukin-8120197000.500 Why?
Anilides320214150.460 Why?
Phosphatidylinositol 3-Kinases1202428780.460 Why?
Receptor, IGF Type 1220133850.440 Why?
Hepatocyte Growth Factor220132680.430 Why?
Vascular Endothelial Growth Factor Receptor-2120155480.400 Why?
Xenograft Model Antitumor Assays8202436080.400 Why?
Insulin-Like Growth Factor I3201319360.350 Why?
Interleukin-62201932220.350 Why?
Vascular Endothelial Growth Factor A2201935130.340 Why?
Class I Phosphatidylinositol 3-Kinases220249040.320 Why?
Neoplasms, Second Primary1201610500.310 Why?
Carcinoma, Renal Cell2202131810.300 Why?
Protein Kinase Inhibitors5202456960.270 Why?
Kidney Neoplasms2202142740.270 Why?
Breast Neoplasms22024210560.260 Why?
Proto-Oncogene Proteins c-bcl-22202414100.250 Why?
Pyridines3202128880.250 Why?
Liver Transplantation1201724120.250 Why?
MicroRNAs2201937850.250 Why?
Carcinoma, Hepatocellular1201723290.240 Why?
NFI Transcription Factors12024490.230 Why?
Carcinoma, Non-Small-Cell Lung2202053890.220 Why?
Prostate1201117550.210 Why?
Bone Neoplasms4201625670.210 Why?
Neoplasm Recurrence, Local2201993730.200 Why?
Antineoplastic Agents72020136480.200 Why?
Gene Expression Regulation, Neoplastic5202486110.190 Why?
Colorectal Neoplasms2201969420.190 Why?
Liver Neoplasms1201743530.190 Why?
Brain Neoplasms2202190710.180 Why?
Signal Transduction82023236010.180 Why?
Antineoplastic Combined Chemotherapy Protocols22019118680.180 Why?
Leukemia, Myeloid, Acute1201636460.180 Why?
Cell Line, Tumor102024170750.180 Why?
Molecular Targeted Therapy1201128220.170 Why?
Fatal Outcome3202018310.170 Why?
Cryoelectron Microscopy120246450.160 Why?
Inflammation12019108500.160 Why?
Orchiectomy220114600.160 Why?
Phosphorylation5202382780.160 Why?
Male2720243636980.150 Why?
Nitriles220249820.150 Why?
Hypernatremia12018780.150 Why?
Benzamides2202413770.150 Why?
Cell Transformation, Neoplastic2202028440.150 Why?
Lung Neoplasms22020134510.140 Why?
Neoplasm Metastasis3201948930.140 Why?
Progesterone120227520.140 Why?
Proto-Oncogene Proteins c-akt2202424530.140 Why?
Hyponatremia120182760.130 Why?
Proto-Oncogene Proteins c-yes12015170.120 Why?
Humans3220247659680.120 Why?
Clinical Trials, Phase II as Topic220156390.120 Why?
Small Cell Lung Carcinoma120204510.120 Why?
Focal Adhesion Kinase 1120151210.120 Why?
Apoptosis5202495140.120 Why?
Chitosan120151380.110 Why?
Receptor, Fibroblast Growth Factor, Type 1120152600.110 Why?
Sodium1201815910.110 Why?
Pyrazoles2202220330.100 Why?
Cell Cycle Proteins1202434300.100 Why?
Ossification, Heterotopic120152390.100 Why?
Chromatin1202429800.100 Why?
Tumor Burden2201518850.100 Why?
Proto-Oncogene Proteins1202445200.100 Why?
Neoplasms, Hormone-Dependent220134090.100 Why?
Taxoids220136650.090 Why?
Gene Knockdown Techniques1201515990.090 Why?
Ubiquitin-Protein Ligases1202018920.090 Why?
Gene Transfer Techniques1201512160.090 Why?
Drug Resistance, Neoplasm2201553370.090 Why?
Multicenter Studies as Topic1201517310.090 Why?
DNA1202472020.080 Why?
Lymphatic Metastasis1201728870.080 Why?
Mice102024818190.080 Why?
Neoplasm Transplantation1201320140.080 Why?
Bone Diseases120124110.080 Why?
Drug Design2201110420.080 Why?
Receptor, Insulin120128370.080 Why?
Animals1320241687640.080 Why?
Integrins120138400.080 Why?
Prognosis22019299220.080 Why?
Disease-Free Survival1201968320.080 Why?
Aged820201711170.070 Why?
RNA Interference2201528320.070 Why?
Mice, Nude4201536180.070 Why?
Heart Diseases1202028210.070 Why?
Autophagy1201513510.070 Why?
Enzyme Activation1201335860.070 Why?
Disease Models, Animal22017182930.070 Why?
Female1020243961120.070 Why?
Cell Proliferation62024104290.070 Why?
Recurrence1201985010.070 Why?
Ligands1201332730.060 Why?
Survival Rate12019127950.060 Why?
Cardiac Surgical Procedures1202036750.060 Why?
Bone and Bones1201525540.060 Why?
Cell Movement2201551940.060 Why?
Carcinoma, Squamous Cell1202040440.060 Why?
Pteridines12024470.060 Why?
Neovascularization, Pathologic1201426310.060 Why?
Neoplasm Staging22017112060.060 Why?
RNA, Small Interfering1201334210.060 Why?
Nanoparticles1201519640.060 Why?
Membrane Proteins1202078510.050 Why?
Receptor Tyrosine Kinase-like Orphan Receptors12023430.050 Why?
Randomized Controlled Trials as Topic12019103830.050 Why?
Protein Binding1201492960.050 Why?
Pyrimidines3202430470.050 Why?
Pandemics1202087030.040 Why?
Drug Synergism1202417490.040 Why?
Follow-Up Studies22019391930.040 Why?
Protein Isoforms1202417180.040 Why?
Alternative Splicing1202411070.040 Why?
Epithelial-Mesenchymal Transition120247520.040 Why?
Mutation12024301980.040 Why?
Transcription, Genetic1201375990.040 Why?
Positron-Emission Tomography1201565470.040 Why?
Basic Helix-Loop-Helix Transcription Factors1202411400.040 Why?
Clinical Trials as Topic2201180410.040 Why?
Algorithms12018140710.040 Why?
Mitosis1202311730.040 Why?
Transfection2201557430.040 Why?
Enzyme-Linked Immunosorbent Assay2201338070.030 Why?
Ubiquitination120209960.030 Why?
Cell Lineage1202425730.030 Why?
Androgens1202312790.030 Why?
Thiazoles2201315290.030 Why?
Disease Progression12011136320.030 Why?
Middle Aged520202230090.030 Why?
Piperazines1202425490.030 Why?
X-Ray Microtomography120154540.030 Why?
Stress, Physiological1202014020.030 Why?
Neoplasm Proteins1202435960.020 Why?
3T3 Cells1201310810.020 Why?
Clinical Trials, Phase I as Topic120133300.020 Why?
Prostate-Specific Antigen2201124640.020 Why?
Neoplasms12020223400.020 Why?
Up-Regulation1202041370.020 Why?
Treatment Outcome22015651880.020 Why?
Multiple Myeloma1200951970.020 Why?
Triazines120123070.020 Why?
Immunoprecipitation120128700.020 Why?
DNA Methylation1202444240.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201545620.020 Why?
Aged, 80 and over32020594890.020 Why?
Osteoblasts1201311430.020 Why?
Mitochondria1202036730.020 Why?
Prednisone1201115650.020 Why?
Infusions, Intravenous1201122290.020 Why?
Comorbidity12020105630.020 Why?
Critical Illness1201827440.020 Why?
Blotting, Western1201250200.020 Why?
Intensive Care Units1201838000.020 Why?
Tumor Cells, Cultured1201261130.010 Why?
Cell Cycle1201229200.010 Why?
Prostatectomy1201117820.010 Why?
Drug Administration Schedule1201148500.010 Why?
Administration, Oral1201140150.010 Why?
Drug Therapy, Combination1201263090.010 Why?
Predictive Value of Tests12018153980.010 Why?
Immunohistochemistry12015110220.010 Why?
Time Factors22015400650.010 Why?
NF-kappa B1200924850.010 Why?
Weight Loss1201127100.010 Why?
Combined Modality Therapy1201185290.010 Why?
Cell Survival1200957470.010 Why?
Cohort Studies12021416490.010 Why?
Retrospective Studies22021815140.010 Why?
Enzyme Inhibitors1200937150.010 Why?
Prospective Studies12021548020.010 Why?
Pain1201150770.010 Why?
Young Adult12018598890.010 Why?
Antibodies, Monoclonal1200992490.010 Why?
Quality of Life12011134620.000 Why?
Adult120182230440.000 Why?
Varkaris's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (184)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.